Has Mathew Wooster, MD received payments from drug or device companies?

Yes. Drug and device makers reported $443,426 in general payments to Mathew Wooster, MD across 1,039 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mathew Wooster, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mathew Wooster, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mathew Wooster, MD

Vascular Surgery · West Columbia, SCNPI 1336415454

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $275,810 of the $443,426 with a category attached, or 62.2%. 26 manufacturers reported payments, led by Shockwave Medical, Inc at 28.9% of the total. Reporting peaked in 2023 at $124,570 and has fallen 52.8% since, to $58,838 in 2025. Among vascular surgery clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$443,426in general payments, 2019–2025

Across 1,039 payments — averaging $426.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Shockwave Medical, Inc$128K
Penumbra, Inc.$97K
Medtronic$78K
Cook Incorporated$59K
W. L. Gore & Associates, Inc.$42K
Philips North America LLC$17K
plus $22K from 20 others

$204,240in research payments, 2019–2025

Across 26 payments — averaging $7855.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Shockwave Medical, Inc$146K
Medtronic$24K
Contego Medical, Inc$17K
Penumbra, Inc.$12K
Cook Research Incorporated$5K

What the payments were for

Consulting fees$66,34315%
Speaking & faculty fees$275,81062%
Travel & lodging$56,45813%
Food & beverage$44,81610%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Shockwave Medical, Inc	97	$128,216
Penumbra, Inc.	167	$96,855
Medtronic(2 entities)	159	$78,049
Cook Incorporated	23	$59,391
W. L. Gore & Associates, Inc.	173	$42,257
Philips North America LLC	26	$16,997
Cook Medical LLC	347	$15,602
Terumo Medical Corporation	5	$1,560
Stryker	4	$743
Bolton Medical Inc	7	$573
Silk Road Medical, Inc.	7	$564
Cook Research Incorporated	2	$430
Inari Medical, Inc.	1	$378
Argon Medical Devices, Inc.	1	$350
Cardiovascular Systems Inc.	3	$325
Boston Scientific	2	$183
Innovation Technologies Inc	1	$156
Shape Memory Medical Inc.	2	$155
Wilson Cook Medical Incorporated	2	$138
Centerline Biomedical Inc.	2	$132
Endologix LLC	2	$122
Bard Peripheral Vascular, Inc.	2	$81
Surmodics, Inc.	1	$63
Abbott	1	$52
Lemaitre Vascular, Inc.	1	$31
Getinge USA Sales, LLC	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$121,574
Indigo System$73,814
Cook$31,507
GORE VIABAHN VBX Balloon Expandable Endo$22,939
(9520) IGT Devices Undivided$15,165
ENDURANT IIS$14,079
GORE VIABAHN Endoprosthesis$12,182
Zilver Vena$11,885
RUBY Coil$10,876
Heli-FX EndoAnchor System$8,950
Abre$8,850
GORE VIABAHN Endoprosthesis with Heparin$8,542
HawkOne$7,815
GORE TAG Thoracic Branch Endoprosthesis$7,290
Indigo$6,700
Zenith Alpha$6,058
Zilver PTX$5,782
GORE EXCLUDER Iliac Branch Endoprosthesis$5,660
IN.PACT Admiral$5,550
Vascular Lithotripsy$5,454

How this compares

$443,426 in reported general payments places this provider in the 95th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$196,019

Medicare patients

837

Services billed

1,504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	13	$11,747
ClopidogrelClopidogrel Bisulfate	44	$581
Cilostazol	16	$435

Paid to pharmacies, not to this prescriber.

Other vascular surgery in West Columbia

Gerald FortunaWest Columbia$143K
Brett FowlerWest Columbia$7K
John RossOrangeburg$847K
David DeatonColumbia$609K
Sagar GandhiGreenville$236K
Ravi VeeraswamyCharleston$164K
Kristian HochbergCharleston$106K
Joseph BlasGreenville$101K
Thomas ApplebyNorth Charleston$89K
Zachary ArthursCharleston$84K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →